Author Question: An employer-funded plan with favorable tax advantages, which repays employees for medical care not ... (Read 84 times)

ts19998

  • Hero Member
  • *****
  • Posts: 531
An employer-funded plan with favorable tax advantages, which repays employees for medical care not covered by the employer's standard medical plan is a(n)
 
  A) 401(k) account.
  B) individual retirement account (IRA).
  C) health reimbursement arrangement (HRA).
  D) flexible spending account (FSA).

Question 2

Which of the following statements regarding recent developments in employer-sponsored health plans is (are) true?
 
  I. Preferred provider organizations (PPOs) continue to dominate group health insurance markets.
  II. The number of employers offering medical benefits to workers who retire early has increased.
  A) I only
  B) II only
  C) both I and II
  D) neither I nor II



coreycathey

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Answer: C

Answer to Question 2

Answer: A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library